The Clorox Company (NYSE:CLX) Shares Bought by Retirement Guys Formula LLC

Retirement Guys Formula LLC grew its position in The Clorox Company (NYSE:CLX) by 18.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 6,436 shares of the company’s stock after purchasing an additional 986 shares during the period. Retirement Guys Formula LLC’s holdings in Clorox were worth $948,000 at the end of the most recent quarter.

Several other institutional investors have also recently modified their holdings of the company. Oppenheimer & Co. Inc. increased its holdings in Clorox by 2.9% in the 1st quarter. Oppenheimer & Co. Inc. now owns 17,422 shares of the company’s stock worth $2,565,000 after buying an additional 493 shares during the period. TrueMark Investments LLC boosted its holdings in shares of Clorox by 8.9% in the 1st quarter. TrueMark Investments LLC now owns 36,702 shares of the company’s stock valued at $5,404,000 after acquiring an additional 2,993 shares during the last quarter. Cambridge Investment Research Advisors Inc. boosted its holdings in shares of Clorox by 106.6% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 85,766 shares of the company’s stock valued at $12,629,000 after acquiring an additional 44,246 shares during the last quarter. Synergy Asset Management LLC acquired a new stake in shares of Clorox in the first quarter worth $350,000. Finally, Intact Investment Management Inc. lifted its position in Clorox by 7,950.0% during the first quarter. Intact Investment Management Inc. now owns 32,200 shares of the company’s stock valued at $4,741,000 after purchasing an additional 31,800 shares during the period. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Stock Performance

CLX opened at $122.33 on Tuesday. The firm’s fifty day simple moving average is $132.74 and its two-hundred day simple moving average is $146.30. The Clorox Company has a 52-week low of $120.33 and a 52-week high of $171.37. The company has a market cap of $15.08 billion, a price-to-earnings ratio of 21.96, a PEG ratio of 2.73 and a beta of 0.54. The company has a quick ratio of 0.44, a current ratio of 0.74 and a debt-to-equity ratio of 13.07.

Clorox (NYSE:CLX) last released its quarterly earnings results on Monday, May 5th. The company reported $1.45 earnings per share for the quarter, missing the consensus estimate of $1.57 by ($0.12). Clorox had a return on equity of 324.23% and a net margin of 9.89%. The company had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.74 billion. During the same quarter last year, the company earned $1.71 EPS. The firm’s revenue for the quarter was down 8.0% on a year-over-year basis. Equities analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the company. Citigroup cut their price target on Clorox from $165.00 to $150.00 and set a “neutral” rating on the stock in a research report on Monday, April 14th. Barclays lowered their target price on Clorox from $134.00 to $129.00 and set an “underweight” rating on the stock in a research note on Wednesday, May 7th. Morgan Stanley decreased their price target on Clorox from $165.00 to $150.00 and set an “equal weight” rating for the company in a report on Tuesday, May 6th. JPMorgan Chase & Co. lowered their price objective on Clorox from $151.00 to $144.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 6th. Finally, Evercore ISI set a $140.00 target price on shares of Clorox and gave the company an “underperform” rating in a report on Tuesday, May 6th. Three equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $151.23.

Insider Buying and Selling at Clorox

In other news, Director Pierre R. Breber purchased 4,000 shares of the stock in a transaction dated Wednesday, May 7th. The shares were purchased at an average cost of $136.57 per share, with a total value of $546,280.00. Following the completion of the purchase, the director now directly owns 4,000 shares of the company’s stock, valued at approximately $546,280. The trade was a ∞ increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Insiders own 0.57% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.